Published in World J Gastroenterol on August 28, 2010
Treatment options in painful chronic pancreatitis: a systematic review. HPB (Oxford) (2013) 1.01
Role of vitamins in gastrointestinal diseases. World J Gastroenterol (2015) 0.82
Antioxidants and chronic pancreatitis: theory of oxidative stress and trials of antioxidant therapy. Dig Dis Sci (2012) 0.77
Does antioxidant therapy influence every aspect of quality of life? World J Gastroenterol (2012) 0.75
Antioxidant therapy in acute, chronic and post-endoscopic retrograde cholangiopancreatography pancreatitis: An updated systematic review and meta-analysis. World J Gastroenterol (2015) 0.75
Prospective evaluation of pain control and quality of life in patients with chronic pancreatitis following bilateral thoracoscopic splanchnicectomy. Surg Endosc (2013) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology (2008) 2.62
A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas (1997) 2.11
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion (1993) 1.71
Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med (2008) 1.59
Revised classification of pancreatitis. Report of the Second International Symposium on the Classification of Pancreatitis in Marseille, France, March 28-30, 1984. Gastroenterology (1985) 1.45
Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol (2005) 1.43
Natural course of chronic pancreatitis. Pancreatology (2001) 1.33
Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther (1990) 1.32
Acute and chronic pancreatitis--diseases on the rise: a study of hospital admissions in England 1989/90-1999/2000. Aliment Pharmacol Ther (2002) 1.20
Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther (1992) 1.18
Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg (2006) 1.07
Dietary antioxidants and chronic pancreatitis. Hum Nutr Clin Nutr (1986) 1.06
Estimation of the prevalence and incidence of chronic pancreatitis and its complications. Gastroenterol Clin Biol (2006) 1.02
Micronutrient antioxidant status in tropical compared with temperate-zone chronic pancreatitis. Scand J Gastroenterol (1993) 1.02
Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile. Acta Oncol (1992) 0.95
A framework for the aetiogenesis of chronic pancreatitis. Digestion (1998) 0.94
Chronic pancreatitis at Manchester, UK. Focus on antioxidant therapy. Digestion (1998) 0.87
Adding methionine to way paracetamol tablet. Methionine is important in treatment of chronic pancreatitis. BMJ (1998) 0.78
Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg (2012) 5.55
Antioxidant therapy does not reduce pain in patients with chronic pancreatitis: the ANTICIPATE study. Gastroenterology (2012) 4.74
Open pancreatic necrosectomy in the multidisciplinary management of postinflammatory necrosis. Ann Surg (2010) 2.97
Mesh fixation at laparoscopic inguinal hernia repair: a meta-analysis comparing tissue glue and tack fixation. World J Surg (2014) 2.66
EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer. Pancreas (2012) 1.65
The use of thrombin injections in the management of bleeding gastric varices: a single-center experience. Gastrointest Endosc (2008) 1.65
European survey of surgical strategies for the management of severe acute pancreatitis. Am J Gastroenterol (2004) 1.56
The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg (2013) 1.52
The end of cryotherapy for the treatment of nonresectable hepatic tumors? Ann Surg Oncol (2005) 1.40
Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol (2004) 1.38
Systematic appraisal of the role of metallic endobiliary stents in the treatment of benign bile duct stricture. Ann Surg (2005) 1.30
Systematic appraisal of the management of the major vascular complications of pancreatitis. Am J Surg (2005) 1.22
Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock (2007) 1.13
Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy. Ann Surg Oncol (2007) 1.11
Markers of angiogenesis in synchronous and in metachronous colorectal hepatic metastases. Ann Surg (2015) 1.08
Understanding the colonic complications of pancreatitis. Pancreatology (2008) 1.04
Cholecystitis after cholecystectomy. J R Soc Med (2002) 1.00
Radiofrequency ablation for locally advanced cancer of the pancreas. JOP (2006) 0.99
Evidence for a central role for selective mesenteric angiography in the management of the major vascular complications of pancreatitis. Am J Surg (2003) 0.98
Development and validation of an experimental model for the assessment of radiofrequency ablation of pancreatic parenchyma. Pancreas (2005) 0.94
Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. Shock (2008) 0.93
TNF-alpha as a therapeutic target in acute pancreatitis--lessons from experimental models. ScientificWorldJournal (2007) 0.90
Centralisation of upper gastrointestinal cancer surgery. Ann R Coll Surg Engl (2007) 0.89
Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. HPB (Oxford) (2011) 0.89
Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis. Pancreas (2007) 0.89
Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Shock (2007) 0.88
Nutritional and anthropometric assessment of the scope for dietary optimization during staging prior to pancreaticoduodenectomy. JOP (2008) 0.87
Epidermal growth factor receptor in pancreatic cancer. Cancers (Basel) (2011) 0.87
Sequential endovascular repair and pancreaticoduodenectomy for abdominal aortic aneurysm copresenting with periampullary cancer. Ann Vasc Surg (2006) 0.83
Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis. Surgery (2005) 0.82
Current status of laparoscopic biliary bypass in the management of non-resectable peri-ampullary cancer. Pancreatology (2005) 0.82
Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis. Crit Care (2005) 0.82
Intravenous selenium modulates L-arginine-induced experimental acute pancreatitis. JOP (2005) 0.81
The performance of organ dysfunction scores for the early prediction and management of severity in acute pancreatitis: an exploratory phase diagnostic study. Pancreas (2010) 0.80
Recombinant human activated protein C (Xigris) attenuates murine cerulein-induced acute pancreatitis via regulation of nuclear factor κB and apoptotic pathways. Pancreas (2012) 0.80
Insulin protects pancreatic acinar cells from cytosolic calcium overload and inhibition of plasma membrane calcium pump. J Biol Chem (2011) 0.80
Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis. Pancreas (2009) 0.80
Recombinant human activated protein C as a disease modifier in severe acute pancreatitis: systematic review of current evidence. Pancreatology (2012) 0.79
Evaluation of the Manchester classification system for chronic pancreatitis. JOP (2006) 0.78
Contemporary management of perihilar cholangiocarcinoma in a nontransplant hepatopancreatobiliary center. Eur J Gastroenterol Hepatol (2013) 0.78
General surgery in patients with a bleeding diathesis: how we do it. World J Surg (2011) 0.78
Poly(adenylic acid) complementary DNA real-time polymerase chain reaction in pancreatic ductal juice in patients undergoing pancreaticoduodenectomy. Pancreas (2010) 0.77
Poly(A) cDNA real-time PCR for indicator gene measurement in cancer. Methods Mol Biol (2010) 0.77
Cytokine profiles in patients receiving antioxidant therapy within the ANTICIPATE trial. World J Gastroenterol (2013) 0.77
Glycolytic ATP fuels the plasma membrane calcium pump critical for pancreatic cancer cell survival. J Biol Chem (2013) 0.77
Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis. Pancreas (2006) 0.77
Contemporary management of infected necrosis complicating severe acute pancreatitis. Crit Care (2006) 0.76
Variance in elective surgery for chronic pancreatitis. JOP (2009) 0.76
Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics. Crit Care (2006) 0.76
Quantitative analysis of plasma DNA in severe acute pancreatitis. JOP (2006) 0.76
Long-term outcome of patients with chronic pancreatitis treated with micronutrient antioxidant therapy. Hepatobiliary Pancreat Dis Int (2017) 0.75
Endoscopic versus surgical treatment for chronic pancreatitis. N Engl J Med (2007) 0.75
Outcome of hepaticojejunostomy without access loop for repair of iatrogenic bile duct injury at laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg (2007) 0.75
Improving definition of the term "synchronous liver metastases" from colorectal cancer. Hepatobiliary Pancreat Dis Int (2016) 0.75
Erratum to: Preventing Inguinodynia After Hernia Surgery: Does the Type of Mesh Matter? World J Surg (2015) 0.75
Practical strategies for case selection in minimally invasive necrosectomy. Pancreatology (2008) 0.75
Contemporary management of pancreatic pseudocysts. Pancreatology (2005) 0.75
Cryoablation for liver tumors - is there clinical utility? MedGenMed (2003) 0.75
Laparoscopic biliary bypass and current management algorithms for the palliation of malignant obstructive jaundice. Ann Surg Oncol (2004) 0.75
Mycotic common iliac artery aneurysm complicating methicillin-resistant Staphylococcus aureus bacteremia: an unusual cause of ureteric obstruction. Ann Vasc Surg (2005) 0.75
Functional protein C levels during the early phase of clinical acute pancreatitis. Pancreas (2010) 0.75